Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Moderna share price: H1 2021 earnings preview

Moderna’s Q2 results are expected to show that sales of its Covid-19 vaccine have more than doubled from the first quarter to boost revenue.

Moderna Source: Bloomberg

When is Moderna earnings date?

Moderna, the messenger ribonucleic acid (mRNA) medicines based company, is expected to release quarter two (Q2) of 2021 results on 5 August 2021. The scheduled results will cover the groups second quarter and half-year earnings (H1).

Moderna results preview: what does the Street expect?

Moderna is expecting a strong first quarter (Q1) to be followed up with an even stronger Q2, boosted by commercial sales of its Covid-19 vaccine. 2021's Q1 saw $1.7 billion in revenue from the three month period as 102 million doses of the Covid-19 vaccine were sold. Moderna in its last results update forecast 200 to 250 million doses to be sold in 2021's Q1. As of the last quarter the group had already signed Advanced Purchase Agreements (APAs) for product sales amounting to $19.2 billion for the full year.

Consensus estimates as sourced from Refinitiv arrive at the following in terms of the groups upcoming results:

  • Revenue for H1 of 2021 of $21.779 million is expected (+74% year on year)
  • Earnings per share (EPS) of $4.25 for H1 of 2021 expected (vs $2.01 in H1 2020)

How to trade the Moderna results

A Refinitiv poll of 18 analysts maintain a long-term average rating of ‘hold’ for Moderna (as of 2 August 2021), with two of these analysts recommending a strong buy, seven recommending a buy, six hold and three sell recommendations on the stock.

Moderna broker rating Source: Refinitiv Data
Moderna broker rating Source: Refinitiv Data

The long-term price target (mean) for Moderna from these analysts is $205.07, suggesting that the share price currently trades at a significant premium (42%) to suggested fair value.

Find out more on how to buy, sell and short Moderna shares

Moderna share price: technical analysis

Moderna chart Source: IG charts
Moderna chart Source: IG charts

The share price of Moderna entered into a strong upward trend at the beginning of May 2021. The aggressive move higher has however moved the share price firmly into overbought territory.

Traders respecting the uptrend will look to keep a long bias to trades, although recognize that the overbought signal suggests that they may be afforded long entry at a better price.

Our preference is look for entry into a pullback towards a confluence of both trendline and gap support around the 260.00 level. Only on a move below the major low at 216.20, would we reassess the uptrend bias currently prevalent.

Summary

  • Moderna results are scheduled for release on 5 August 2021
  • Revenue for H1 2021 of $21.779 million is expected (+74% year on year)
  • EPS of $4.25 for H1 of 2021 are expected (vs $2.01 in H1 2020)
  • The long-term price target (mean) for Moderna is $205.07
  • The long-term trend for Moderna remains up, although the share price is overbought in the near term

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.